Process development of the CCK2 receptor ligand

ORGN 237

Luigi Anzalone, Lanzalon@prdus.jnj.com1, Ahmed F. Abdel-Magid, AMAGID@prdus.jnj.com1, Judith Cohen, JCohen@CRDUS.JNJ.com2, Steven Mehrman1, and Frank J. Villani Jr., fvillani@prdus.jnj.com1. (1) Chemical Development, Johnson & Johnson Pharmaceutical Research and Development L.L.C, Welsh & McKean Rds, Spring House, PA 19477, (2) Cordis Corporation, Welsh & McKean Roads, Spring House, PA 19477-0779
The process development of the cholecystokinin (CCK2) receptor ligand 1 is described with the emphasis on the scale-up modifications needed to manufacture kilogram quantities of crystalline material. The modifications include (a) the use of 2-chloro-1-cyclopentylethanone as the alkylating agent rather than the less stable bromo-analog, (b) the use of thionyl chloride/acetonitrile to introduce the amide linkage, and (c) the selection of the choline salt. Moreover a cost efficient synthesis of a key intermediate will be disclosed. This synthesis is based on a highly regio-selective addition of an aryl isocyanate to a substituted hydrazine.

 

Combinatorial and Process Chemistry
8:00 AM-11:40 AM, Monday, March 26, 2007 McCormick Place East -- Room E350, Level 3, Oral

Division of Organic Chemistry

The 233rd ACS National Meeting, Chicago, IL, March 25-29, 2007